| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/04/2026 | ±4.0% | +7.0% | under-priced |
| 04/30/2026 | ±2.7% | -4.2% | under-priced |
| 02/03/2026 | ±2.7% | -6.3% | under-priced |
| 11/04/2025 | ±2.4% | +0.8% | over-priced |
| 08/05/2025 | ±2.1% | +6.8% | under-priced |
| 05/01/2025 | ±2.1% | -5.9% | under-priced |
| 01/31/2025 | ±1.5% | -0.4% | over-priced |
| 11/05/2024 | ±1.3% | +4.1% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q4 FY2026 | — | $2.2B | $398M |
| Q3 FY2026 | $2.36 | $2.0B | $276M |
| Q2 FY2026 | $2.42 | $1.7B | $285M |
| Q1 FY2026 | $1.40 | $1.6B | $165M |
BR (BR) reports in 7 days, with the next report estimated for 11/03/2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 4.4% on average — the market has tended to under-price BR's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 7.5%. QuantLogix's live 5-factor engine currently reads BR as a buy at 74/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →